Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-24-075201
Filing Date
2024-03-22
Accepted
2024-03-22 16:05:48
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 d803890d424b5.htm 424B5 5503
2 GRAPHIC g803890g0322002908824.jpg GRAPHIC 3636
  Complete submission text file 0001193125-24-075201.txt   11705
Mailing Address 4000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 4000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-822-5600
Kezar Life Sciences, Inc. (Filer) CIK: 0001645666 (see all company filings)

EIN.: 473366145 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-261774 | Film No.: 24775210
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)